Following myomectomy the rate of fertility is restored and pregnancy may be attempted with a good outcome. In the present study a 3 month treatment with OCs in a group of women after a myomectomy was evaluated. The drug compliance and side effects, the benefits of OC in order to reduce symptoms, to increase post-surgical hemoglobin levels and to avoid an early pregnancy after myomectomy were analyzed. A group of women (n = 55) each with myoma ≥ 5cm was recruited: they presented menorrhagia, pelvic pain, dyspareunia and dysmenorrhae. After laparotomic myomectomy the women were divided into 3 groups. Group 1: women (n = 16) treated with pill A (15mcg of ethynilestradiol + 60mcg of gestodene); group 2: women (n = 23) treated with pill B (20mcg of ethynilestradiol + 100mcg of levonorgestrel); group 3: women (n = 16) treated with a placebo (oral calcium). After three months from myomectomy and treatment patients in each group reported a reduced menorrhagia, dismenorrhea and pelvic pain. Serum haemoglobin levels increased in all women (P
CITATION STYLE
Petraglia, F., Luisi, S., Ciani, V., Gabbanini, M., Sollazzi, S., Torricelli, M., & Calonaci, F. (2009). Oral contraceptives after myomectomy: A short term trial. International Journal of Endocrinology, 2009. https://doi.org/10.1155/2009/476897
Mendeley helps you to discover research relevant for your work.